Form 4: Astera Labs Director Executes Planned Stock Sale

Director Jack R. Lazar sold shares of Astera Labs, Inc. following a scheduled RSU grant and pre-arranged trading plan.

Summary

• Director Jack R. Lazar received an award of 837 restricted stock units (RSUs) on June 4, 2026.
• The director sold a total of 9,853 shares of common stock on June 4, 2026.
• The sales were executed automatically pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2025.
• Following these transactions, the director holds 75,688 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transactions were pre-planned and represent standard portfolio management by a director.

Positives

• The transactions were conducted under a pre-established Rule 10b5-1 trading plan, indicating the sales were not based on non-public information.
• The director continues to maintain a significant equity stake of 75,688 shares in the company.

Negatives

• The director reduced their total beneficial ownership through the sale of 9,853 shares.

Risks

• Future share price volatility may impact the value of the director's remaining holdings.
• The director's continued service is required for the vesting of the newly granted RSUs.

Future Outlook

The newly granted RSUs are scheduled to vest in full on the earlier of the first anniversary of the grant date or the date of the next annual stockholder meeting, contingent upon continued service.

Management Comments

• The reporting person has committed to providing full information regarding the number of shares sold at each separate price within the reported ranges upon request.

Industry Context

StockSavvy.ai notes that routine insider selling under 10b5-1 plans is a standard corporate governance practice for executives and directors, typically intended to provide liquidity rather than signaling a lack of confidence in the company's long-term prospects.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for directors to manage equity holdings while avoiding potential insider trading concerns.
• The vesting schedule for the RSUs aligns with typical equity incentive structures for technology company board members.

Stakeholder Impact

• Shareholders should view these transactions as routine insider activity rather than a change in company strategy or outlook.

Next Steps

• Vesting of the 837 RSUs on the earlier of June 4, 2027, or the next annual stockholder meeting.

Key Dates

Keywords

Astera Labs, ALAB, Insider Trading, Form 4, Director, Equity Compensation